Diakron Pharmaceuticals Overview
- Founded
-
1998
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Diakron Pharmaceuticals General Information
Description
Developer of cardiovascular drug. The company is engaged in drug discovery for cardiovascular related fields. It has development programs targeting clotting disorders, hypertension and diabetes.
Contact Information
Website
www.diakron.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
- P.O. Box 748
- Morris Plains, NJ 07950
- United States
Diakron Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Diakron Pharmaceuticals Patents
Diakron Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2012336036-A1 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
| CA-2857953-A1 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
| EP-2780016-A1 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
| EP-2780016-A4 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
| US-20140309239-A1 | Extended release formulation of a direct thrombin inhibitor | Active | 07-Nov-2011 | A61K31/497 |